Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Viracept 625mg tablets (Agouron Pharmaceuticals, Inc) 120 tablet |
Has NHS dm+d (dictionary of medicines and devices) controlled drug category |
Controlled drug category No Controlled Drug Status |
true |
Inferred relationship |
Existential restriction modifier |
|
|
Viracept 625mg tablets (Agouron Pharmaceuticals, Inc) 120 tablet |
Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator |
NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction imported |
true |
Inferred relationship |
Existential restriction modifier |
|
|
Viracept 625mg tablets (Agouron Pharmaceuticals, Inc) 120 tablet |
Is a |
Nelfinavir 625mg tablets 120 tablet |
true |
Inferred relationship |
Existential restriction modifier |
|
|
Viracept 625mg tablets (Agouron Pharmaceuticals, Inc) 120 tablet |
Is pack of |
Viracept 625mg tablets (Agouron Pharmaceuticals, Inc) |
false |
Inferred relationship |
Existential restriction modifier |
|
|
Viracept 625mg tablets (Agouron Pharmaceuticals, Inc) 120 tablet |
Has active ingredient |
Nelfinavir |
false |
Inferred relationship |
Existential restriction modifier |
|
|
Viracept 625mg tablets (Agouron Pharmaceuticals, Inc) 120 tablet |
Has manufactured dose form |
Tablet |
false |
Inferred relationship |
Existential restriction modifier |
|
|
Viracept 625mg tablets (Agouron Pharmaceuticals, Inc) 120 tablet |
Has excipient |
Excipient not declared |
true |
Inferred relationship |
Existential restriction modifier |
|
|
Viracept 625mg tablets (Agouron Pharmaceuticals, Inc) 120 tablet |
Discontinued indicator |
Never discontinued |
true |
Inferred relationship |
Existential restriction modifier |
|
|
Viracept 625mg tablets (Agouron Pharmaceuticals, Inc) 120 tablet |
Legal category |
Prescription only medicine - legal category (qualifier value) |
true |
Inferred relationship |
Existential restriction modifier |
|
|
Viracept 625mg tablets (Agouron Pharmaceuticals, Inc) 120 tablet |
VMP prescribing status (attribute) |
VMP valid as a prescribable product |
true |
Inferred relationship |
Existential restriction modifier |
|
|
Viracept 625mg tablets (Agouron Pharmaceuticals, Inc) 120 tablet |
VMP non-availability indicator |
Available |
true |
Inferred relationship |
Existential restriction modifier |
|
|
Viracept 625mg tablets (Agouron Pharmaceuticals, Inc) 120 tablet |
Has AMP |
Viracept 625mg tablets (Agouron Pharmaceuticals, Inc) |
true |
Inferred relationship |
Existential restriction modifier |
|
|
Viracept 625mg tablets (Agouron Pharmaceuticals, Inc) 120 tablet |
Has NHS dm+d (dictionary of medicines and devices) basis of strength substance |
Nelfinavir |
true |
Inferred relationship |
Existential restriction modifier |
|
|
Viracept 625mg tablets (Agouron Pharmaceuticals, Inc) 120 tablet |
Has specific active ingredient |
Nelfinavir mesilate |
true |
Inferred relationship |
Existential restriction modifier |
|
|
Viracept 625mg tablets (Agouron Pharmaceuticals, Inc) 120 tablet |
Has dispensed dose form |
Tablet |
true |
Inferred relationship |
Existential restriction modifier |
|
|
Viracept 625mg tablets (Agouron Pharmaceuticals, Inc) 120 tablet |
Is a |
Actual medicinal product pack |
true |
Inferred relationship |
Existential restriction modifier |
|
|
Viracept 625mg tablets (Agouron Pharmaceuticals, Inc) 120 tablet |
Has basis of strength substance |
Nelfinavir |
true |
Inferred relationship |
Existential restriction modifier |
|
|